Centogene N V Net Income per Employee (CNTG), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Centogene N v   (NASDAQ: CNTG)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Centogene N V Net Income per Employee

CNTG's Quarterly Results, Trends, Rankings, Statistics
Centogene N V recorded a cumulative net loss of $-40 million during 12 month ending in the fourth quarter 2023.
The Healthcare sector has seen employees of 23 other companies achieving higher income per employee. While Centogene N V 's total ranking has deteriorated compared to the previous quarter from 0 to 3629.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CNTG Net Income per Employee (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -99,490 -89,155 -89,155 -116,714 -135,164
CNTG's Total Ranking # 3629 # 0 # 0 # 0 # 2629
Seq. Net Income Change - - - - -

CNTG Company Profile >> Back to CNTG Efficiency Comparisons >> Compare CNTG Net Income per Employee to its Competitors

CNTG Net Income per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 24
Healthcare Sector # 354
Overall Market # 3629

Net Income per Employee Statistics
High Average Low
$ -89,155 $ -106,610 $ -131,186
(Dec 31 2022)   (Dec 31 2021)




  News about Centogene N v Income per employee

CENTOGENE Expands Relationship with Lifera and Secures $20 Million to Strengthen Cash Position


recently reported on CENTOGENE s expanding relationship with Lifera, a biopharma company owned by the PIF. This news comes as CENTOGENE N.V. recorded a cumulative net loss of $-36 million during the 12 months ending in the fourth quarter of 2022.
Despite facing challenges in the Medical Laboratories industry, with employees of 14 other companies reaching higher income per employee, CENTOGENE N.V. s overall ranking has deteriorated compared to the third quarter of 2022, dropping from 0 to 2629.
In response to these financial pressures, CENTOGENE has secured approximately $20 million to strengthen its cash position. This strategic move not only bolsters the company s financial stability but also paves the way for further growth and collaboration with LiferaThe partnership between CENTOGENE and Lifera demonstrates a commitment to innovation and advancement in the biopharma industry. With this influx of funds, CENTOGENE is well-positioned to navigate market challenges and drive future success.





Companies with similar Income per Employee for 12 month ending Dec 31 2023, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2023Number of Employees Dec 31 2023


Date modified: 2026-09-08T15:11:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.